SCHEMBL518519

SCHEMBL518519

CC(C)CCCCCCCNCCCCCCCC(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.48
TSHR P16473 2/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP2C19 P33261 3/20 0.41
CYP1A2 P05177 3/20 0.41
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CA12 O43570 2/20 0.36
F13A1 P00488 2/20 0.36
CA2 P00918 2/20 0.36
ALOX15 P16050 2/20 0.36
CA4 P22748 2/20 0.36
CA6 P23280 2/20 0.36
CA5A P35218 2/20 0.36
THPO P40225 2/20 0.36
CA7 P43166 2/20 0.36
CA9 Q16790 2/20 0.36
CA14 Q9ULX7 2/20 0.36
CA5B Q9Y2D0 2/20 0.36
CASP2 P42575 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28897325 1.00 LMNA (0.48) LMNATSHRALDH1A1CYP2C19CYP1A2
SCHEMBL516335 1.00 LMNA (0.48) LMNATSHRALDH1A1CYP2C19CYP1A2
SCHEMBL240286 1.00 LMNA (0.48) LMNATSHRALDH1A1CYP2C19CYP1A2
SCHEMBL1507434 1.00 LMNA (0.48) LMNATSHRALDH1A1CYP2C19CYP1A2
SCHEMBL1507386 1.00 LMNA (0.48) LMNATSHRALDH1A1CYP2C19CYP1A2
SCHEMBL24346553 1.00 LMNA (0.48) LMNATSHRALDH1A1CYP2C19CYP1A2
SCHEMBL518293 1.00 LMNA (0.48) LMNATSHRALDH1A1CYP2C19CYP1A2
SCHEMBL1507574 1.00 LMNA (0.48) LMNATSHRALDH1A1CYP2C19CYP1A2
SCHEMBL1507533 1.00 LMNA (0.48) LMNATSHRALDH1A1CYP2C19CYP1A2
SCHEMBL1507527 1.00 LMNA (0.48) LMNATSHRALDH1A1CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110669058-A Tricyclic quinolone carboxylic acid and preparation method thereof 江西农业大学 2020-01-10 CN claimed
US-9226925-B1 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder PISGAH LABORATORIES, INC. (US) 2016-01-05 US claimed
US-8940729-B1 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder PISGAH LABORATORIES, INC. (US) 2015-01-27 US claimed
US-8912217-B1 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder PISGAH LABORATORIES, INC. (US) 2014-12-16 US claimed
CN-119799302-A Oil-soluble thick oil viscosity reducer and preparation method and application thereof 中国石油化工股份有限公司 2025-04-11 CN disclosed
CN-119677819-A Azo compound or salt thereof, and polarizing film, polarizing plate and liquid crystal display device each containing the same 日本化药株式会社 2025-03-21 CN disclosed
CN-114026199-B Polarized light emitting film, polarized light emitting panel and display device containing water-soluble coumarin compound or salt thereof 日本化药株式会社 2023-12-26 CN disclosed
CN-113430373-B Method for separating rare earth elements 福建省长汀金龙稀土有限公司 2022-11-04 CN disclosed
CN-114302870-A N, N-dialkyl amino carboxylic acid and preparation method and application thereof 厦门钨业股份有限公司 2022-04-08 CN disclosed
CN-113430373-A Method for separating rare earth elements 厦门钨业股份有限公司 2021-09-24 CN disclosed
CN-110669058-A Tricyclic quinolone carboxylic acid and preparation method thereof 江西农业大学 2020-01-10 CN disclosed
US-20190248958-A1 PREPARATION METHOD OF OLIGOMER ADDITIVE, OLIGOMER ADDITIVE, AND LITHIUM BATTERY NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) 2019-08-15 US disclosed
US-5183842-A Mixture of ketoacid and amine with film-forming binder, curing CIBA-GEIGY CORPORATION (US) 1993-02-02 US disclosed
US-5134050-A Photoreceptor comprising the combined use of a quinone and azo compound as charge generating materials KONICA CORPORATION (JP) 1992-07-28 US disclosed
US-5128396-A Corrosion inhibiting primers on metallic substrates CIBA-GEIGY CORPORATION (US) 1992-07-07 US disclosed
US-5068094-A Liquid-liquid extraction using amine salts CHEMISCHE FABRIK BUDENHEIM RUDOLF A. OETKER (DE) 1991-11-26 US disclosed
EP-0412933-A1 Coating compositions CIBA-GEIGY AG (CH) 1991-02-13 EP disclosed
EP-0399521-A2 Process for extracting cadmium-ions from wet process phosphoric acid Chemische Fabrik Budenheim Rudolf A. Oetker (DE) 1990-11-28 EP disclosed
US-4939058-A Durability KONICA CORPORATION (JP) 1990-07-03 US disclosed
EP-0322586-A2 Photo-receptor for electrophotography KONICA CORPORATION (JP) 1989-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190248958-A1 PREPARATION METHOD OF OLIGOMER ADDITIVE, OLIGOMER ADDITIVE, AND LITHIUM BATTERY PCNA, SCO2, PARG LMNA 16/4885TSHR 4451/4885ALDH1A1 3550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.